Prevalence and recurrence rate of colonic lesions in acromegalic patients

[1] Koenuma M., Yamori T., Tsuruo T., Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26, Jpn J Cancer Res., 1989, 80, 51–58 10.1111/j.1349-7006.1989.tb02244.xSearch in Google Scholar

[2] Watkins LF., Lewis LR., Levine AE., Characterization of the synergistic effect of insulin and transferring and the regulation of their receptors on a human colon carcinoma cell line, Int J Cancer., 1990, 45, 372–375 http://dx.doi.org/10.1002/ijc.291045022710.1002/ijc.2910450227Search in Google Scholar

[3] Bjork J., Nilsson J., Hultcrantz R., Johansson C., Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the nontransformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29, Scand J Gastroenterol., 1993, 28, 879–884 http://dx.doi.org/10.3109/0036552930910312910.3109/00365529309103129Search in Google Scholar

[4] Hansen I., Tsalikian E., Beaufrere B., Gerich J., Haymond M., Rizza R., Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action, Am J Physiol., 1986, 250, E269–273 10.1152/ajpendo.1986.250.3.E269Search in Google Scholar

[5] McKeown-Eyssen G., Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk?, Cancer Epidemiol Biomarkers Prev., 1994, 3, 687–695 Search in Google Scholar

[6] La Vecchia C., Negri E., Franceschi S., D’Avanzo B., Boyle P., A case-control study of diabetes mellitus and cancer risk, Br J Cancer., 1994, 70, 950–953 10.1038/bjc.1994.427Search in Google Scholar

[7] Le Marchand L., Wilkens LR., Kolonel LN., Hankin JH., Lyu LC., Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer, Cancer Res., 1997, 57, 4787–4794 Search in Google Scholar

[8] Sandhu MS., Luben R., Khaw KT., Self reported noninsulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study, J Epidemiol Community Health., 2001, 55, 804–805 http://dx.doi.org/10.1136/jech.55.11.80410.1136/jech.55.11.804Search in Google Scholar

[9] Ron E., Gridley G., Hrubec Z., Page W., Arora S., Fraumeni JF Jr., Acromegaly and gastrointestinal cancer, Cancer., 1991, 68, 1673–1677 http://dx.doi.org/10.1002/1097-0142(19911015)68:8<1673::AID-CNCR2820680802>3.0.CO;2-010.1002/1097-0142(19911015)68:8<1673::AID-CNCR2820680802>3.0.CO;2-0Search in Google Scholar

[10] Pines A., Rozen P., Ron E., Gilat T., Gastrointestinal tumors in acromegalic patients, Am J Gastroenterol., 1985, 80, 266–269 Search in Google Scholar

[11] Baris D., Gridley G., Ron E., Weiderpass E., Mellemkjaer L., Ekbom A., et al., Acromegaly and cancer risk: a cohort study in Sweden and Denmark, Cancer Causes Control., 2002, 13, 395–400 http://dx.doi.org/10.1023/A:101571373271710.1023/A:1015713732717Search in Google Scholar

[12] Ladas SD., Thalassinos NC., Ioannides G., Raptis SA., Does acromegaly really predispose to an increased prevalence of gastrointestinal tumours?, Clin Endocrinol (Oxf)., 1994, 41, 597–601 http://dx.doi.org/10.1111/j.1365-2265.1994.tb01824.x10.1111/j.1365-2265.1994.tb01824.xSearch in Google Scholar

[13] Ortego J., Vega B., Sampedro J., Escalada J., Boixeda D., Varela C., Neoplastic colonic polyps in acromegaly, Horm Metab Res., 1994, 26, 609–610 http://dx.doi.org/10.1055/s-2007-100176910.1055/s-2007-1001769Search in Google Scholar

[14] Renehan AG., Bhaskar P., Painter JE., O’Dwyer ST., Haboubi N., Varma J., et al., The prevalence and characteristics of colorectal neoplasia in acromegaly, J Clin Endocrinol Metab., 2000, 85, 3417–3424 http://dx.doi.org/10.1210/jc.85.9.341710.1210/jc.85.9.3417Search in Google Scholar

[15] Jenkins PJ., Besser M., Clinical perspective: acromegaly and cancer: a problem, J Clin Endocrinol Metab., 2001, 86, 2935–2941 http://dx.doi.org/10.1210/jc.86.7.293510.1210/jcem.86.7.7634Search in Google Scholar

[16] Jenkins PJ., Fairclough PD., Colorectal neoplasia in acromegaly, Clin Endocrinol (Oxf)., 2001, 55, 727–729 http://dx.doi.org/10.1046/j.1365-2265.2001.01418.x10.1046/j.1365-2265.2001.01418.xSearch in Google Scholar

[17] Atkin WS., Risk of colorectal neoplasia in acromegaly: an independent view, Clin Endocrinol (Oxf)., 2001, 55, 723–725 http://dx.doi.org/10.1111/j.1365-2265.2001.01410.x10.1111/j.1365-2265.2001.01410.xSearch in Google Scholar

[18] Colao A., Pivonello R., Auriemma RS., Galdiero M., Ferone D., Minuto F., et al., The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients, J Clin Endocrinol Metab., 2007, 92, 3854–3860 http://dx.doi.org/10.1210/jc.2006-255110.1210/jc.2006-2551Search in Google Scholar

[19] Kurimoto M., Fukuda I., Hizuka N., Takano K., The prevalence of benign and malignant tumors in patients with acromegaly at a single institute, Endocr J., 2008, 5, 67–71 http://dx.doi.org/10.1507/endocrj.K07E-01010.1507/endocrj.K07E-010Search in Google Scholar

[20] Levin B., Lieberman DA., McFarland B., Andrews KS., Brooks D., Bond J., et al., American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology., 2008, 134, 1570–1595 http://dx.doi.org/10.1053/j.gastro.2008.02.00210.1053/j.gastro.2008.02.002Search in Google Scholar

[21] Inoue M., Iwasaki M., Otani T., Sasazuki S., Noda M., Tsugane S., Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan, Arch Intern Med., 2006, 166, 1871–1877 http://dx.doi.org/10.1001/archinte.166.17.187110.1001/archinte.166.17.1871Search in Google Scholar

[22] Ragozzino M., Melton LJ 3d., Chu CP., Palumbo PJ., Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus, J Chronic Dis., 1982, 35, 13–19 http://dx.doi.org/10.1016/0021-9681(82)90025-X10.1016/0021-9681(82)90025-XSearch in Google Scholar

[23] La Vecchia C., Negri E., Decarli A., Franceschi S., Diabetes mellitus and colorectal cancer risk, Cancer Epidemiol Biomarkers Prev., 1997, 6, 1007–1010 Search in Google Scholar

[24] Hu FB., Manson JE., Liu S., Hunter D., Colditz GA., Michels KB., et al., Prospective study of adult onset diabetes mellitus (Type 2) and risk of colorectal cancer in women, J Natl Cancer Inst., 1999, 91, 542–547 http://dx.doi.org/10.1093/jnci/91.6.54210.1093/jnci/91.6.542Search in Google Scholar PubMed

[25] Jee SH., Ohrr H., Sull JW., Yun JE., Ji M., Samet JM., Fasting serum glucose level and cancer risk in Korean men and women, JAMA., 2005, 293, 194–202 http://dx.doi.org/10.1001/jama.293.2.19410.1001/jama.293.2.194Search in Google Scholar

[26] Yang YX., Hennessy S., Lewis JD., Type 2 diabetes mellitus and the risk of colorectal cancer, Clin Gastroenterol Hepatol., 2005, 3, 587–594 http://dx.doi.org/10.1016/S1542-3565(05)00152-710.1016/S1542-3565(05)00152-7Search in Google Scholar

[27] Nilsen TI., Vatten LJ., Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI. Exploring the hyperinsulinaemia hypothesis, Br J Cancer., 2001, 84, 417–422 http://dx.doi.org/10.1054/bjoc.2000.158210.1054/bjoc.2000.1582Search in Google Scholar

[28] Larsson SC., Orsini N., Wolk A., Diabetes mellitus and risk of colorectal cancer: a meta-analysis, J Natl Cancer Inst., 2005, 97, 1679–1687 http://dx.doi.org/10.1093/jnci/dji37510.1093/jnci/dji375Search in Google Scholar

[29] MacDonald RS., Thornton WH Jr., Bean TL., Insulin and IGE-1 receptors in a human intestinal adenocarcinoma cell line (CACO-2): regulation of Na+ glucose transport across the brush border, J Recept Res., 1993, 13, 1093–1113 10.3109/10799899309063266Search in Google Scholar

[30] Guo YS., Narayan S., Yallampalli C., Singh P., Characterization of insulin like growth factor I receptors in human colon cancer, Gastroenterology., 1992, 102, 1101–1108 10.1016/0016-5085(92)90744-JSearch in Google Scholar

[31] Warren RS., Yuan H., Matli MR., Ferrara N., Donner DB., Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma, J Biol Chem., 1996, 271, 29483–29488 http://dx.doi.org/10.1074/jbc.271.46.2948310.1074/jbc.271.46.29483Search in Google Scholar PubMed

[32] Giovannucci E., Pollak MN., Platz EA., Willett WC., Stampfer MJ., Majeed N., et al., A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women, Cancer Epidemiol Biomarkers Prev., 2000, 9, 345–349 Search in Google Scholar

[33] Ma J., Pollak MN., Giovannucci E., Chan JM., Tao Y., Hennekens CH., et al., Prospective study of colorectal cancer risk in men and plasma levels of insulin like growth factor (IGF)-I and IGF-binding protein-3, J Natl Cancer Inst., 1999, 91, 620–625 http://dx.doi.org/10.1093/jnci/91.7.62010.1093/jnci/91.7.620Search in Google Scholar PubMed

[34] Juul A., Pedersen SA., Sørensen S., Winkler K., Jørgensen JO., Christiansen JS., et al., Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset, Eur J Endocrinol., 1994, 131, 41–49 http://dx.doi.org/10.1530/eje.0.131004110.1530/eje.0.1310041Search in Google Scholar PubMed

[35] Ghigo E., Aimaretti G., Maccario M., Fanciulli G., Arvat E., Minuto F., et al., Doseresponse study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women, Am J Physiol., 1999, 276, E1009–1013 10.1152/ajpendo.1999.276.6.E1009Search in Google Scholar PubMed

[36] Giovannucci E., Pollak M., Risk of cancer after growth hormone treatment, Lancet., 2002, 360, 268–269 http://dx.doi.org/10.1016/S0140-6736(02)09561-210.1016/S0140-6736(02)09561-2Search in Google Scholar

[37] Cohen P., Fielder PJ., Hasegawa Y., Frisch H., Giudice LC., Rosenfeld RG., Clinical aspects of insulin-like growth factor binding proteins, Acta Endocrinol (Copenh)., 1991, 124, 74–85 Search in Google Scholar

[38] Nam SY., Lee EJ., Kim KR., Cha BS., Song YD., Lim SK., et al., Effect of obesity on total and free insulin-like growth factor (IGF)-I and their relationship to IGFbinding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone, Int J Obes Relat Metab Disord., 1997, 21, 355–359 http://dx.doi.org/10.1038/sj.ijo.080041210.1038/sj.ijo.0800412Search in Google Scholar PubMed

[39] Orme SM., McNally RJ., Cartwright RA., Belchetz PE., Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group, J Clin Endocrinol Metab., 1998, 83, 2730–2734 http://dx.doi.org/10.1210/jc.83.8.273010.1210/jc.83.8.2730Search in Google Scholar

[40] Barzilay J., Heatley GJ., Cushing GW., Benign and malignant tumors in patients with acromegaly, Arch Intern Med., 1991, 151, 1629–1632 http://dx.doi.org/10.1001/archinte.151.8.162910.1001/archinte.151.8.1629Search in Google Scholar

[41] Colao A., Balzano A., Ferone D., Panza N., Grande G., Marzullo P., et al., Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly, Clin Endocrinol (Oxf)., 1997, 47, 23–28 http://dx.doi.org/10.1046/j.1365-2265.1997.00253.x10.1046/j.1365-2265.1997.00253.xSearch in Google Scholar PubMed

[42] Delhougne B., Deneux C., Abs R., Chanson P., Fierens H., Laurent-Puig P., et al., The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients, J Clin Endocrinol Metab., 1995, 80, 3223–3226 http://dx.doi.org/10.1210/jc.80.11.322310.1210/jc.80.11.3223Search in Google Scholar

[43] Pawlikowski M., Lachowicz L., Kunert-Radek J., Winczyk K., Janiszewska G., Szkudlarek J., Differential effects of somatostatin and its analog on protein tyrosine kinases activity in the rat pituitary and the murine colonic tumors, Biochem Biophys Res Commun., 1998, 246, 375–377 http://dx.doi.org/10.1006/bbrc.1998.862410.1006/bbrc.1998.8624Search in Google Scholar PubMed